Presentations
-
04:00pm - 05:00pm ETSpeaker: Jacob Jordan, MD, MS - Mayo Clinic Alix School of Medicine, Rochester
-
04:00pm - 05:00pm ET
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab with Doxorubicin, Concurrent Atezolizumab with Preoperative Radiotherapy, and Adjuvant Atezolizumab in Patients with High-Risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
Speaker: Ahsan Farooqi, MD, PhD - University of Texas MD Anderson Cancer Center, Houston -
04:00pm - 05:00pm ET
Beyond Palliation: Survival Advantage of Definitive Primary Tumor Treatment In Oligometastatic Sarcoma
Speaker: Yiqun Han, MD - Mayo Clinic Rochester, Rochester -
04:00pm - 05:00pm ETSpeaker: Zoe Cosner, MD - Harvard Radiation Oncology Program, Boston
-
04:00pm - 05:00pm ETSpeaker: Noah Kalman, MD, MBA - Miami Cancer Institute, Miami
-
04:00pm - 05:00pm ET
Merkel Cell Carcinoma of the Scalp: The Effect of Head and Neck Anatomic Subsite on Recurrence Patterns and Outcomes
Speaker: Michael Bian, BS - Case Western Reserve University, Cleveland -
04:00pm - 05:00pm ET
Fractionation-Dependent Immune Remodeling and Toxicity following Hypofractionated Radiation in Soft-Tissue Sarcoma
Speaker: Logan Mahoney, - University of Calgary, Calgary -
04:00pm - 05:00pm ET
Phase I Study of Neoadjuvant Atezolizumab plus Concurrent SBRT in Borderline Resectable or Unresectable Cutaneous Squamous Cell Carcinoma: Preliminary Safety and Efficacy Results
Speaker: Kim Vo, DO, MS - City of Hope Comprehensive Cancer Center, Duarte -
04:00pm - 05:00pm ET
Clinical Application and Efficacy Observation of SGRT in Precision Radiotherapy for Extremity Malignant Tumors
Speaker: Lin Yang, - Department of Radiotherapy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province -
04:00pm - 05:00pm ET
A Pilot Study of Pembrolizumab Combined with Stereotactic Ablative Radiotherapy for Patients with Metastatic Sarcoma
Speaker: Jeremy Harris, MD, MPhil - University of California, Irvine, Orange -
04:00pm - 05:00pm ET
Updated Outcomes of Moderately Hypofractionated Definitive Radiotherapy (MHDT) Using a Simultaneous Integrated Boost (SIB) for Inoperable Non-Extremity Sarcomas
Speaker: Sheetal Patel, - University College London Hospital, London -
04:00pm - 05:00pm ET
Repair Type and Risk of Wound Healing Complications after Surgery and Adjuvant Radiotherapy for Non-Melanoma Skin Cancer
Speaker: David Konieczkowski, MD, PhD - James Cancer Hospital, The Ohio State University, Columbus -
04:00pm - 05:00pm ET
Perioperative Simultaneous Integrated Boost Radiotherapy for Undifferentiated Pleomorphic Sarcoma: Real-World Outcomes and Patterns of Local Failure
Speaker: Jingyao Zhang, - Peking University Cancer Hospital, Beijing -
04:00pm - 05:00pm ET
Response Evaluation and Prognostic Factors in Soft Tissue Sarcoma Patients Treated with Preoperative Hypofractionated Radiotherapy
Speaker: Ece Ercan, MD - Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul -
04:00pm - 05:00pm ET
Evaluating the Effect of Tumor-Draining Nodal Irradiation By Flash vs. Conventional Dose-Rate Radiotherapy of a Clinically Relevant Melanoma Mouse Model
Speaker: Patrick Carriere, MD, PhD - MD Anderson Cancer Center, Houston -
04:00pm - 05:00pm ET
Quantitative Dosimetric Analysis of Patterns of Local Recurrence (LR) after IMRT for Primary Undifferentiated Pleomorphic Sarcoma (UPS) of the Extremity
Speaker: Jacob Shin, MD - Memorial Sloan Kettering Cancer Center, New York -
04:00pm - 05:00pm ET
Interstitial and Hybrid HDR vs. PDR Brachytherapy for Non-Melanoma Skin Cancer: Comparative Effectiveness and Toxicity from a Single-Institution Cohort
Speaker: Adam Kluska, MD, PhD - Medical university of Lodz, Lodz -
04:00pm - 05:00pm ET
Oncologic Outcomes and Prognostic Determinants Following Neoadjuvant Radiotherapy and Surgical Resection in Myxoid Liposarcoma
Speaker: Daniela Greto, MD - Azienda Ospedaliera Universitaria Careggi, Firenze -
04:00pm - 05:00pm ET
Characteristics, Management, and Outcomes of Localized Chondrosarcoma: A Single-Institution Retrospective Study
Speaker: Ojasvi Appana, - The Ohio State University, Columbus -
04:00pm - 05:00pm ET
Detecting Local and Metastatic Recurrences after Treatment of Soft Tissue Sarcomas: Periodicity and Duration of Surveillance
Speaker: Emmanuel Jnr Amoateng, MD - University of Rochester Medical Center, Rochester -
04:00pm - 05:00pm ET
Outcomes and Prognostic Factors after Metastasis Directed Radiation in Patients with Metastatic Sarcoma
Speaker: Jaitri Joshi, MS - University of Minnesota Medical School, Minneapolis -
04:00pm - 05:00pm ET
Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) to Optimize the Outcome for Neoadjuvant Radiotherapy in Soft Tissue Sarcoma (STS)
Speaker: Arash Naghavi, MD, MS - H. Lee Moffitt Cancer Center and Research Institute, Tampa -
04:00pm - 05:00pm ETSpeaker: Dianna Liakos, BS - Medical College of Wisconsin, Milwaukee
-
04:00pm - 05:00pm ET
Long-Term Outcomes for Localized Leiomyosarcoma of the Extremity and Superficial Trunk Treated with Surgery and Radiation Therapy
Speaker: Jordan McDonald, MD - MD Anderson Cancer Center, Houston -
04:00pm - 05:00pm ET
The Impact of Radiotherapy Quality on Patient Outcomes in Pediatric Multicenter Clinical Trials: A Systematic Review and Meta-Analysis
Speaker: Vaishvi Patel, MD - Cross Cancer Institute, Edmonton -
04:00pm - 05:00pm ET
Leveraging H3K27M-Driven ATR Dependency to Enhance the Efficacy of Radiotherapy for Diffuse Midline Gliomas
Speaker: Khushi Kohli, BS - Harvard Medical School, Boston -
04:00pm - 05:00pm ET
Long-Term Outcomes and Toxicities Following Radiotherapy for Progressive Pediatric Low-Grade Gliomas After Systemic Therapy
Speaker: Sanjana Shah, BS - Harvard Medical School, Boston -
04:00pm - 05:00pm ETSpeaker: Brittney Chau, MD - University of Southern California/Los Angeles General Medical Center, Los Angeles
-
04:00pm - 05:00pm ET
Extrachromosomal and Complex Amplicons are Independent Prognostic Markers inPediatric Medulloblastoma
Speaker: Nikol Mladkova, MD, PhD, MPH - Westchester Medical Center, Valhalla -
04:00pm - 05:00pm ETSpeaker: Melanie Rose, MD, MS - Mass General Brigham Cancer Institute, Boston
-
04:00pm - 05:00pm ET
Survival and Neurologic Outcomes after Re-Irradiation in Children with Diffuse Midline Glioma and Diffuse Intrinsic Pontine Glioma
Speaker: Tina Vaziri, MD - Johns Hopkins Hospital, Baltimore -
04:00pm - 05:00pm ET
-
04:00pm - 05:00pm ET
Radiation Pneumonitis after Contemporary Whole Lung Irradiation in Pediatric Sarcomas and Wilms Tumor
Speaker: Ory Haisraely, MD, MPH - MD Anderson Cancer Center, Houston -
04:00pm - 05:00pm ETSpeaker: Melisa Pasli, MD - Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville
-
04:00pm - 05:00pm ET
Imaging-Based Deep Learning for Brain Age Prediction following Radiation Therapy in Pediatric Medulloblastoma
Speaker: Anna Zapaishchykova, PhD - Harvard Medical School, Boston -
04:00pm - 05:00pm ET
VMAT-Based Total Body Irradiation for Pediatric Conditioning: Prospective Feasibility and Dosimetric Outcomes
Speaker: Umesh Velu, - Kasturba Medical College, Manipal -
04:00pm - 05:00pm ET
Clinical Observation and Timing Log-File Dose Reconstruction of Phantosmia in Pediatric Patients Undergoing Proton Craniospinal Irradiation
Speaker: Heather Stebbeds, BS - St Jude Children's Research Hospital, Memphis -
04:00pm - 05:00pm ET
Thyroid, Cardiac and Pulmonary Function Abnormalities Following Consolidative Radiotherapy in Pediatric and Young Adult Hodgkin and Primary Mediastinal B-Cell Lymphoma Patients
Speaker: Katherine Von Werne, MSN - Miami Cancer Institute: Baptist Health South Florida, Miami -
04:00pm - 05:00pm ET
Prospective Treatment of Types I, II, and III Pleuropulmonary Blastoma (PPB): A COG Groupwide Phase 3 Study (ARAR2331)
Speaker: John Lucas, MD, MS - St. Jude Children's Research Hospital, Memphis -
04:00pm - 05:00pm ET
Lymphopenia and Neutropenia During Radiotherapy Independently Predict Overall Survival in Chemotherapy-Naïve Patients with Molecularly-characterized Medulloblastoma
Speaker: Isaac Lasko, MD - Loyola University Medical Center, Maywood -
04:00pm - 05:00pm ET
To Radiate or Not: The Role of Consolidative Radiotherapy to Post-Induction MIBG-Avid Sites in High-Risk Neuroblastoma
Speaker: Ainsley Merritt, - UT Southwestern Medical School, Dallas -
04:00pm - 05:00pm ET
Toxicity and Survival Analysis of Vertebral-Body-Sparing Proton Craniospinal Irradiation in Pediatric Patients
Speaker: Chuyu Xia, MD - Peking University First Hospital, Beijing -
04:00pm - 05:00pm ET
Simultaneous Integrated Boost vs. Sequential Boost for Postoperative Intensity-Modulated Radiotherapy of Extremity and Trunk Soft Tissue Sarcomas: A Propensity Score Matching-Based Large-Scale Retrospective Analysis
Speaker: Shi-Jie Yang, - Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing -
04:00pm - 05:00pm ET
Motion Management in Pediatric Radiotherapy: Assessment of Intrafraction Motion Using an Audio/Visual Distraction Method
Speaker: Andrew Puthran, BS - Indiana University School of Medicine, Indianapolis -
04:00pm - 05:00pm ETSpeaker: Katherine Schumacher, MD - SUNY Upstate Radiation Oncology, Syracuse
-
04:00pm - 05:00pm ET
Brachytherapy vs. External Beam Radiation In Gynecologic Rhabdomyosarcoma: A Retrospective Survival Analysis
Speaker: Luke Limfueco, BS - Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona -
04:00pm - 05:00pm ET
Molecular Subgroup Specific Long-Term Outcomes of Modern Proton Therapy In Medulloblastoma- An Institution Experience
Speaker: Uday Krishna As, MD, DNB - Apollo Proton Cancer Centre, Chennai -
04:00pm - 05:00pm ET
A Phase III Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Lorlatinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (ANBL1531)
Speaker: Christine Hill-Kayser, MD - University of Pennsylvania, Philadelphia -
04:00pm - 05:00pm ET
Integrating Gene Expression and Clinical Variables Improves Prediction of Disease Progression in Neuroblastoma: A Secondary Analysis of the SEQC Cohort
Speaker: Soumyajit Roy, MBBS, MSc. - University Hospitals Seidman Cancer Center, Cleveland -
04:00pm - 05:00pm ET
Leptomeningeal Failure in Pediatric Parameningeal Rhabdomyosarcoma: Predictive Factors and Opportunities for Prevention
Speaker: Nidhi Shah, BS - AU/UGA Medical Partnership, Athens -
04:00pm - 05:00pm ET
Hormone Replacement Therapy is Not Linked to Photon Beam-Induced Vasculopathy in Children and Adolescents with Craniopharyngioma
Speaker: Soziema Dauda, BS - UTHSC College of Medicine, Memphis -
04:00pm - 05:00pm ET
Patterns of Care and Outcomes of Palliative Radiation Therapy to Mesothelial Thoracic Metastases in Children and Young Adults with Osteosarcoma
Speaker: Ahmed Elmotayam, MD - Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston -
04:00pm - 05:00pm ET
Local Control After Stereotactic Radiosurgery for Pediatric Brain Tumors: Updated Systematic Review and Meta-Analysis
Speaker: Lucas Pari Mitre, MD - UT Southwestern, Dallas -
04:00pm - 05:00pm ETSpeaker: Ainsley Merritt, - UT Southwestern Medical School, Dallas
-
04:00pm - 05:00pm ETSpeaker: Joshua Qian, MD - Memorial Sloan Kettering Cancer Center, New York
-
04:00pm - 05:00pm ET
Outcomes Following Combined Modality Local Therapy vs. Surgery Alone for Patients with Non-Metastatic Intrathoracic Soft Tissue Sarcomas
Speaker: Tejaswi Kanala, MD, MBBS - MD Anderson Cancer Center, Houston -
04:00pm - 05:00pm ET
Treatment Outcomes and Toxicities of Stereotactic Body Radiation Therapy for Sarcomas Involving Weight-Bearing Bones - A Single Institution Study
Speaker: Jonathan Bastick, MD - Cleveland Clinic Foundation, Cleveland -
04:00pm - 05:00pm ETSpeaker: Danielle Arons, MD - Mount Sinai Hospital, New York
-
04:00pm - 05:00pm ETSpeaker: Robert Chuter, - The Christie NHS, Manchester
-
04:00pm - 05:00pm ET
Biophilic Design In Oncology Care: A Systematic Review Identifying Evidence Gaps In Built-Environment Interventions
Speaker: Paige Cote, - Tufts University School of Medicine, Boston -
04:00pm - 05:00pm ETSpeaker: Daya Nand Sharma, MD - All India Institute of Medical Sciences, New Delhi
-
04:00pm - 05:00pm ET
Extreme Hypofractionation as a LINAC-Equivalent Capacity Strategy: A National Public Radiotherapy Network Analysis from Chile
Speaker: Piero Bettoli, MD, MS - Instituto Nacional del Cancer, Santiago -
04:00pm - 05:00pm ET
Feasibility Study to Build the First Outpatient Music Therapy Program in a Large Regional Cancer Center: A Survey among the Entire Radiation Oncology Staff
Speaker: Victoria Pan, - Windsor Regional Hospital Cancer Program, Windsor -
04:00pm - 05:00pm ET
Guideline-Directed Hypofractionation Improves Patient Access While Preserving Productivity at a Satellite Academic Radiation Oncology Center
Speaker: Zaker Rana, MD - University of Maryland Medical Center, Baltimore -
04:00pm - 05:00pm ET
Clinical Workflow Cost Analysis of Parallel vs. Sequential MR-Linac SBRT for Prostate and Pancreatic Cancer using Time-Driven Activity-Based Costing
Speaker: Wing Yun Au, BS - University of Virginia Health Systems, Charlottesville -
04:00pm - 05:00pm ETSpeaker: Huzaifah Mahmood, MD - New York Presbyterian Hospital Columbia Campus, New York
-
04:00pm - 05:00pm ET
AI Guided Trigger Implementation to Improve Online Adaptive Radiotherapy Efficiency and System Level Resource Allocation
Speaker: Jiao Yang, PhD - China National Academy of Educational Sciences (CNAES), Beijing -
04:00pm - 05:00pm ET
Savings and the Opportunity for Expanded Treatment Access with Advent Biosimilar Denosumab: A U.S. Perspective
Speaker: Kunal Shastri, - Fresenius Kabi SwissBioSim GmbH, Eysins -
04:00pm - 05:00pm ETSpeaker: Noor Malik, MBBS - University of Lancashire, Preston
-
04:00pm - 05:00pm ET
Age-Related Disparities in Radiotherapy Utilisation: A National Population-Based Study Benchmarking Against Optimal Utilisation
Speaker: Aisling Barry, MBBS, MSc, FFR RCSI, FRCPC - University College Cork, Cork -
04:00pm - 05:00pm ET
Environmental Impact of Prostate Radiation Therapy: Modeling Emissions and Reduction Through Hypofractionation
Speaker: Jessie Karten, DO, BS - Northwell Health Cancer Institute, Lake Success -
04:00pm - 05:00pm ET
Site-Specific Patterns of Acute Care Utilization during Radiation Therapy: A Large-Scale Informatics Analysis Identifying Differential Prevention Opportunities
Speaker: Miriam Lane, MD - University of California Los Angeles, Los Angeles -
04:00pm - 05:00pm ETSpeaker: Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
-
04:00pm - 05:00pm ET
Cost Burden of Non-Metastatic Cervical Cancer in a Commercially Insured US Population: A National Claims-Based Analysis
Speaker: Ria Brown, MD, BS - Emory University School of Medicine, Atlanta -
04:00pm - 05:00pm ETSpeaker: Vedant Tiwari, - University of California, Irvine, Orange
-
04:00pm - 05:00pm ETSpeaker: William Chen, MD - Northwell, New Hyde Park
-
04:00pm - 05:00pm ET
National Radiotherapy Utilization and Health-System Recovery after COVID-19: A Population-Level Public Insurance Analysis
Speaker: Gonzalo Ulloa, MD, MPH - Pontificia Universidad Catolica de Chile, Santiago -
04:00pm - 05:00pm ET
Proton vs. Photon Radiotherapy for Patients with Oropharyngeal Cancer in the USA: A Cost-Effectiveness Analysis
Speaker: Steven Frank, MD, FASTRO - MD Anderson Cancer Center, Houston -
04:00pm - 05:00pm ET
Radiotherapy Access, Infrastructure Gaps and Financial Burden in Bangladesh: A National Landscape Analysis from a Lower-Middle-Income Country
Speaker: Nowshin Hossain, MD - Ahsania Mission Cancer and General Hospital, Dhaka -
04:00pm - 05:00pm ET
Assessment of Burnout Amongst Oncologists Located In a Canadian Province: A Cross-Sectional Survey Analysis
Speaker: Saveen Sidhoo, MD, BS - University of Alberta, Edmonton -
04:00pm - 05:00pm ET
A 'Pop Up' Hands On Procedural Workshop for Radiation Oncology: Creating a Practical Education Module on a Limited Budget
Speaker: Michael Cummings, MD - University of Rochester Medical Center - Department of Medicine, Rochester -
04:00pm - 05:00pm ETSpeaker: Sean McCauley, MD - Mayo Clinic Arizona, Phonix
-
04:00pm - 05:00pm ETSpeaker: Jacob Mapp, MD - Mayo Clinic Arizona, Phonix
-
04:00pm - 05:00pm ET
Perceptions and Attitudes of Oncology Trainees Toward Professional Development through a Multidisciplinary Leadership Journal Club
Speaker: Michael Aboujaoude, BS - University of South Florida Morsani College of Medicine, Tampa -
04:00pm - 05:00pm ET
The Evolution of Medical Students' Interest in Radiation Oncology: From Student Interest Group Events to Residency Application
Speaker: Julia Shi, BS - University of Texas Southwestern Medical Center, Dallas -
04:00pm - 05:00pm ET
Quality and Content of YouTube Videos on Breast Cancer Radiation Therapy Side Effects: A Cross-Sectional Study
Speaker: Sneha Venkat, - K A P Viswanatham Government Medical College, Trichy -
04:00pm - 05:00pm ETSpeaker: Emily Ishak, MD, BS - University of Pennsylvania, Philadelphia
-
04:00pm - 05:00pm ET
Following the ROADMAP: Demographic Results from a Second National Cross-Sectional Survey of Radiation Oncologists Regarding Academic Mentorship
Speaker: Colin McNamara, MSN - Dartmouth Geisel School of Medicine, Lebanon -
04:00pm - 05:00pm ETSpeaker: James Ninia, MD, MS - Yale Therapeutic Radiology, New Haven
-
04:00pm - 05:00pm ET
Impact of a Structured Research Process Initiative on Resident Research Quality: A Mixed-Methods Program Evaluation
Speaker: Poonam Dalwadi, MD, BS - Washington University/B-JH/SLCH Consortium, St. Louis -
04:00pm - 05:00pm ET
Integrating Radiation Oncology Cases into Anatomy: An Opportunity to Incorporate Radiation Oncology into the Curriculum
Speaker: Geina Iskander, MD - University of Texas Southwestern Medical Center, Dallas -
04:00pm - 05:00pm ET
-
04:00pm - 05:00pm ET
Utility of a Radiation Oncology Didactic Lecture for Internal Medicine Trainees: A Single Institution Pilot Study
Speaker: Samuel To, MD - St. Joseph's Medical Center, Stockton -
04:00pm - 05:00pm ET
Two-Year National Reassessment of Digital Resource Comprehensiveness among U.S. Radiation Oncology Residency Programs
Speaker: David Lee, MD - Sylvester Comprehensive Cancer Center, University of Miami, Miami -
04:00pm - 05:00pm ETSpeaker: Matthew Thoonkuzhy, MD - Tufts Medical Center, Boston
-
04:00pm - 05:00pm ETSpeaker: Bryan Webb, MD, PhD - Emory University, Atlanta
-
04:00pm - 05:00pm ETSpeaker: Eric Ford, PhD, FASTRO - University of Washington / Fred Hutch Cancer Center, Seattle
-
04:00pm - 05:00pm ETSpeaker: Nancy Zhou, MD - Kaiser Permanente Los Angeles Medical Center, Los Angeles
-
04:00pm - 05:00pm ETSpeaker: Advaita Chaudhari, - Dartmouth College, Hanover
-
04:00pm - 05:00pm ETSpeaker: Oliver Micke, MD - Franziskus Hospital, Bielefeld
-
04:00pm - 05:00pm ET
Optimizing Radiation Oncology Workplace Productivity and Well-Being through Digital Media: A Performance Evaluation of the "Time Titans" Podcast
Speaker: Madhav Patel, MD, BS - Columbia Presbyterian Medical Center, New York -
04:00pm - 05:00pm ETSpeaker: Diancil Ibarra Llamas, - Facultad de Medicina, UANL, Monterrey
-
04:00pm - 05:00pm ET
Radiation Oncology Awareness and Education within U.S. Internal Medicine Residency: Effects from an Intervention Study
Speaker: Peter Zaki, MD - Loma Linda University Medical Center, Loma Linda -
04:00pm - 05:00pm ET
Development of an Oncology Trainee-Focused Educational Tool to Characterize Enrollment Bias In Early Stage Breast Cancer Trials
Speaker: Ryan Smith, MD, PhD - University of Minnesota, Minneapolis